P200015S024

None

FDA Premarket Approval P200015 S024

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP200015S024
Classification NameNone
Applicant
PMAP200015
SupplementS024

Supplemental Filings

Supplement NumberDateSupplement Type
P200015Original Filing
S031 2022-10-25 30-day Notice
S030 2022-10-04 30-day Notice
S029
S028
S027 2022-08-25 30-day Notice
S026
S025
S024
S023 2022-06-30 30-day Notice
S022 2022-06-06 30-day Notice
S021 2022-05-25 Normal 180 Day Track No User Fee
S020
S019 2022-04-04 30-day Notice
S018
S017 2022-01-14 30-day Notice
S016 2021-11-03 Normal 180 Day Track No User Fee
S015 2021-10-19 30-day Notice
S014 2021-09-30 30-day Notice
S013 2021-08-30 30-day Notice
S012 2021-08-25 30-day Notice
S011
S010 2021-06-07 Normal 180 Day Track No User Fee
S009 2021-03-19 Normal 180 Day Track No User Fee
S008 2021-02-22 30-day Notice
S007 2020-12-17 30-day Notice
S006 2020-12-03 30-day Notice
S005
S004 2020-09-08 30-day Notice
S003 2020-11-17 30-day Notice
S002 2020-11-02 30-day Notice
S001

NIH GUDID Devices

Device IDPMASupp
00690103210866 P200015 011
00690103210873 P200015 011

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.